Question follow-through · 5817

Pancreatic Enzyme Replacement Therapy: Shortages

To ask the Secretary of State for Health and Social Care, what assessment he has made of the effectiveness of the Serious Shortage Protocols in place for?Creon?10,000 and 25,000 capsules limiting prescriptions to one months’ supply; and what steps he is t

answeredDepartment of Health and Social Care

About this written question

A written question asks a government minister for information in writing. Parliament publishes the question and any answer.

Answering body
Department of Health and Social Care
Tabled
12 Sept 2024
Target answer date
7 Oct 2024
Answer
8 Oct 2024 · 26 calendar days after tabling

Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.

More questions by this MP on Health and care

Shared topic keywords suggest a connection; they do not establish a follow-up.

Votes on this topic

These Commons divisions share a topic label. The question did not necessarily lead to a vote.

Recorded timeline

  1. 12 Sept 2024

    Question tabled

    To ask the Secretary of State for Health and Social Care, what assessment he has made of the effectiveness of the Serious Shortage Protocols in place for?Creon?10,000 and 25,000 capsules limiting prescriptions to one months’ supply; and what steps he is t

  2. 7 Oct 2024

    Target answer date

    Date supplied by the official written-questions record.

  3. 8 Oct 2024

    Answer published

    The Department has been working with suppliers to address current supply issues with pancreatic enzyme replacement therapy (PERT), including Creon, to help ensure patients, including children with cystic fibrosis, have access to this medicine. The supply ...

Open official record

Official data retrieved 27 Sept 2026.

Later records

Possible follow-up questions

Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Prescriptions: Fees and Charges

4 Oct 2024 · To ask the Secretary of State for Health and Social Care, whether he plans to review the list of conditions for exemption from prescription charges; and if he will make an assessment of the potential merits of including cystic fibrosis on that list.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Inflammatory Bowel Disease: Medical Treatments

7 Oct 2024 · To ask the Secretary of State for Health and Social Care, if his Department will publish a strategy for ensuring people living with (a) Crohn’s disease and (b) other forms of inflammatory bowel disease are able to access treatment in a timely manner.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Cancer: Medical Treatments

7 Oct 2024 · To ask the Secretary of State for Health and Social Care, if he will take steps to ensure that the new NHS Commercial Framework allows for increased use of indication-specific pricing agreements to support patient access to future cancer innovations.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Children: Death

15 Oct 2024 · To ask the Secretary of State for Health and Social Care, for what reason his Department's Notification of Child Death Form asks about the gender with which the child identified at the time of their death in cases where the child was over 10; and whether

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Ovarian Cancer: Health Education

22 Oct 2024 · To ask the Secretary of State for Health and Social Care, whether he plans to launch a campaign to raise public awareness of the symptoms of ovarian cancer.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Ovarian Cancer: Health Services

22 Oct 2024 · To ask the Secretary of State for Health and Social Care, what steps he plans to take to ensure all women across England with ovarian cancer get access to the best possible treatment.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Hospices

14 Nov 2024 · To ask the Secretary of State for Health and Social Care, what short-term steps his Department is taking to help support hospices to maintain levels of service; and whether his Department is taking long-term steps to reform funding for hospices.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Pharmacy: Staff

26 Nov 2024 · To ask the Secretary of State for Health and Social Care, if he will introduce regulations to ensure that a pharmacist is always present in an open pharmacy to facilitate the sale of pharmacy medicines,

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Trastuzumab Deruxtecan

16 Dec 2024 · To ask the Secretary of State for Health and Social Care, whether his Department plans to take steps to encourage further negotiation between (a) NICE, (b) Daiichi Sankyo Company, Limited and (c) AstraZeneca on the supply of Enhertu.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Dental Services: Finance

3 Jan 2025 · To ask the Secretary of State for Health and Social Care, whether any funding previously allocated to the Dental Recovery Plan has been withdrawn.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Defibrillators: Railway Stations

9 Jan 2025 · To ask the Secretary of State for Health and Social Care, if his Department will take steps to help ensure that emergency services are provided with up to date information on the (a) location and (b) status of defibrillators installed at train stations.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Defibrillators: Railway Stations

9 Jan 2025 · To ask the Secretary of State for Health and Social Care, if his Department will take steps to ensure that all defibrillators installed at train stations are (a) registered and (b) visible on The Circuit national defibrillator network website.